Share Price and Basic Stock Data
Last Updated: December 5, 2025, 7:17 pm
| PEG Ratio | 0.99 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aarti Surfactants Ltd operates in the specialty chemicals sector, focusing on surfactants and other chemical products. The company reported a revenue of ₹601 Cr for FY 2023, showing a modest increase from ₹576 Cr in FY 2022. However, the latest annual figures reveal a slight decline to ₹590 Cr in FY 2024, followed by a projected rise to ₹659 Cr in FY 2025. This fluctuation indicates that while the company has been able to maintain a certain level of sales, it faces challenges in consistently growing its revenue. The trailing twelve months (TTM) revenue stands at ₹732 Cr, suggesting a rebound in sales momentum, especially with quarterly revenues reaching ₹215.90 Cr in Jun 2025. However, the revenue growth should be viewed in the context of rising competition in the specialty chemicals market, which could pressure margins and demand.
Profitability and Efficiency Metrics
Profitability for Aarti Surfactants appears to be under pressure, as indicated by the operating profit margin (OPM) which stood at 6% for FY 2025, down from 11% in FY 2024. The company recorded a net profit of ₹15 Cr for FY 2025, a decline from ₹21 Cr in FY 2024. The net profit margin also reflects this trend, declining to 2.20% in FY 2025 from 3.61% in FY 2024. The interest coverage ratio (ICR) of 3.93x indicates that the company has a comfortable ability to meet its interest obligations, though the persistent low net profit margin may raise concerns about long-term profitability. Additionally, the cash conversion cycle (CCC) of 71 days suggests that while the company is managing its working capital reasonably well, there is still room for improvement in operational efficiency.
Balance Sheet Strength and Financial Ratios
Aarti Surfactants’ balance sheet shows a mixed picture. With total borrowings of ₹118 Cr against reserves of ₹228 Cr, the company appears to have a manageable debt level, reflected in a debt-to-equity ratio of 0.37x. This suggests a relatively low reliance on debt financing, which is a positive sign for investors. However, the return on equity (ROE) at 5.14% and return on capital employed (ROCE) at 8.50% are relatively low compared to industry standards, indicating that while the company is not heavily leveraged, it may not be utilizing its capital as effectively as it could be. The book value per share has increased to ₹274.78, which can be seen as a positive indicator. Yet, with a price-to-book value (P/BV) ratio of 1.46x, the stock may not be seen as undervalued, which could deter some investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aarti Surfactants reveals that promoters hold 49.92% of the company, which suggests a strong commitment from management. However, foreign institutional investors (FIIs) have minimal involvement, holding just 0.00%, while domestic institutional investors (DIIs) own a mere 0.80%. This lack of institutional backing may indicate a level of caution among larger investors, potentially reflecting concerns about the company’s profitability and growth prospects. The public shareholding stands at 49.26%, with over 37,000 shareholders, which shows a reasonable level of retail investor interest. However, the declining trend in the number of shareholders from 41,711 in Dec 2023 to 37,015 in Sep 2025 could signal waning confidence, especially if the company continues to deliver underwhelming financial results.
Outlook, Risks, and Final Insight
Looking ahead, Aarti Surfactants faces both opportunities and challenges. The specialty chemicals market is expected to grow, providing potential avenues for revenue enhancement. However, the company’s declining profitability metrics raise concerns about its ability to capitalize on this growth. Risks include increasing competition, potential raw material price volatility, and the necessity for efficient operational management to improve margins. Investors may want to consider the company’s ability to innovate and adapt to market demands, as well as its capacity to enhance shareholder value amid a challenging economic landscape. Overall, while Aarti Surfactants has strengths in its manageable debt levels and committed management, the ongoing issues with profitability and investor sentiment warrant a cautious approach for potential investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aarti Surfactants Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 402 Cr. | 43.8 | 86.4/42.2 | 25.0 | 20.5 | 0.91 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 34.0 Cr. | 69.3 | 103/56.0 | 16.3 | 89.6 | 1.44 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.2 Cr. | 665 | 988/600 | 20.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,583 Cr. | 79.0 | 111/74.5 | 23.7 | 22.0 | 0.63 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 656 Cr. | 263 | 453/241 | 23.6 | 93.8 | 0.95 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,764.44 Cr | 718.36 | 65.36 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 158.13 | 151.77 | 133.55 | 157.84 | 148.70 | 143.86 | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.90 |
| Expenses | 146.63 | 143.00 | 119.98 | 143.94 | 133.90 | 127.60 | 122.02 | 144.21 | 133.79 | 147.12 | 153.89 | 182.36 | 204.27 |
| Operating Profit | 11.50 | 8.77 | 13.57 | 13.90 | 14.80 | 16.26 | 16.73 | 14.34 | 9.62 | 3.72 | 8.89 | 19.69 | 11.63 |
| OPM % | 7.27% | 5.78% | 10.16% | 8.81% | 9.95% | 11.30% | 12.06% | 9.04% | 6.71% | 2.47% | 5.46% | 9.75% | 5.39% |
| Other Income | 0.10 | 0.09 | 0.06 | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 | 0.49 | 6.21 | -0.16 | 1.14 | 0.04 |
| Interest | 2.98 | 3.74 | 4.16 | 3.91 | 3.32 | 3.66 | 3.65 | 3.41 | 2.57 | 2.60 | 3.12 | 3.26 | 3.28 |
| Depreciation | 3.49 | 4.06 | 4.01 | 3.93 | 3.95 | 3.85 | 4.02 | 4.21 | 4.23 | 4.31 | 4.40 | 4.41 | 4.35 |
| Profit before tax | 5.13 | 1.06 | 5.46 | 6.15 | 7.56 | 8.78 | 9.09 | 6.77 | 3.31 | 3.02 | 1.21 | 13.16 | 4.04 |
| Tax % | 27.68% | 69.81% | 27.11% | 23.90% | 30.56% | 45.90% | 26.40% | 31.17% | 32.93% | 40.07% | 33.88% | 26.22% | 27.23% |
| Net Profit | 3.71 | 0.32 | 3.98 | 4.69 | 5.25 | 4.74 | 6.68 | 4.65 | 2.22 | 1.81 | 0.80 | 9.72 | 2.94 |
| EPS in Rs | 4.36 | 0.38 | 4.68 | 5.52 | 6.18 | 5.58 | 7.86 | 5.50 | 2.62 | 2.14 | 0.95 | 11.49 | 3.48 |
Last Updated: August 20, 2025, 12:50 am
Below is a detailed analysis of the quarterly data for Aarti Surfactants Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 215.90 Cr.. The value appears strong and on an upward trend. It has increased from 202.05 Cr. (Mar 2025) to 215.90 Cr., marking an increase of 13.85 Cr..
- For Expenses, as of Jun 2025, the value is 204.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.36 Cr. (Mar 2025) to 204.27 Cr., marking an increase of 21.91 Cr..
- For Operating Profit, as of Jun 2025, the value is 11.63 Cr.. The value appears to be declining and may need further review. It has decreased from 19.69 Cr. (Mar 2025) to 11.63 Cr., marking a decrease of 8.06 Cr..
- For OPM %, as of Jun 2025, the value is 5.39%. The value appears to be declining and may need further review. It has decreased from 9.75% (Mar 2025) to 5.39%, marking a decrease of 4.36%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.14 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 1.10 Cr..
- For Interest, as of Jun 2025, the value is 3.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.26 Cr. (Mar 2025) to 3.28 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 4.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.41 Cr. (Mar 2025) to 4.35 Cr., marking a decrease of 0.06 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.04 Cr.. The value appears to be declining and may need further review. It has decreased from 13.16 Cr. (Mar 2025) to 4.04 Cr., marking a decrease of 9.12 Cr..
- For Tax %, as of Jun 2025, the value is 27.23%. The value appears to be increasing, which may not be favorable. It has increased from 26.22% (Mar 2025) to 27.23%, marking an increase of 1.01%.
- For Net Profit, as of Jun 2025, the value is 2.94 Cr.. The value appears to be declining and may need further review. It has decreased from 9.72 Cr. (Mar 2025) to 2.94 Cr., marking a decrease of 6.78 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.48. The value appears to be declining and may need further review. It has decreased from 11.49 (Mar 2025) to 3.48, marking a decrease of 8.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:05 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 466 | 576 | 601 | 590 | 659 | 732 |
| Expenses | 302 | 420 | 543 | 554 | 528 | 617 | 688 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 42 | 44 |
| OPM % | 7% | 10% | 6% | 8% | 11% | 6% | 6% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 8 | 7 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 17 |
| Profit before tax | 3 | 23 | 9 | 18 | 32 | 21 | 21 |
| Tax % | 29% | 6% | 41% | 29% | 34% | 30% | |
| Net Profit | 2 | 22 | 5 | 13 | 21 | 15 | 15 |
| EPS in Rs | 2.46 | 25.45 | 6.46 | 14.94 | 25.22 | 17.19 | 18.06 |
| Dividend Payout % | 0% | 11% | 0% | 0% | 0% | 6% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1000.00% | -77.27% | 160.00% | 61.54% | -28.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1077.27% | 237.27% | -98.46% | -90.11% |
Aarti Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 28% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -17% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:16 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 103 | 125 | 128 | 160 | 210 | 224 | 228 |
| Borrowings | 109 | 152 | 162 | 149 | 99 | 110 | 118 |
| Other Liabilities | 42 | 102 | 105 | 86 | 105 | 134 | 135 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
| Fixed Assets | 151 | 187 | 173 | 207 | 208 | 204 | 201 |
| CWIP | 14 | 20 | 52 | 8 | 8 | 15 | 29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 97 | 180 | 178 | 188 | 206 | 259 | 260 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
Below is a detailed analysis of the balance sheet data for Aarti Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 228.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 228.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 118.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 110.00 Cr. (Mar 2025) to 118.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 135.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 490.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 201.00 Cr.. The value appears to be declining and may need further review. It has decreased from 204.00 Cr. (Mar 2025) to 201.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 259.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 490.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (228.00 Cr.) exceed the Borrowings (118.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -85.00 | -106.00 | -130.00 | -101.00 | -37.00 | -68.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 20 | 43 | 35 | 40 | 43 | 42 |
| Inventory Days | 83 | 76 | 60 | 60 | 81 | 92 |
| Days Payable | 28 | 81 | 56 | 44 | 55 | 63 |
| Cash Conversion Cycle | 75 | 38 | 38 | 55 | 69 | 71 |
| Working Capital Days | -1 | 3 | 16 | 20 | 40 | 36 |
| ROCE % | 13% | 7% | 11% | 15% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.20 | 26.63 | 16.64 | 7.25 | 28.53 |
| Diluted EPS (Rs.) | 17.19 | 25.16 | 16.47 | 7.25 | 28.53 |
| Cash EPS (Rs.) | 37.67 | 44.13 | 35.50 | 23.65 | 44.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Revenue From Operations / Share (Rs.) | 778.53 | 696.75 | 757.16 | 758.81 | 614.11 |
| PBDIT / Share (Rs.) | 53.62 | 73.54 | 60.53 | 42.76 | 60.08 |
| PBIT / Share (Rs.) | 33.13 | 54.60 | 41.03 | 26.35 | 43.98 |
| PBT / Share (Rs.) | 24.45 | 38.02 | 22.41 | 12.29 | 30.21 |
| Net Profit / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| NP After MI And SOA / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| PBDIT Margin (%) | 6.88 | 10.55 | 7.99 | 5.63 | 9.78 |
| PBIT Margin (%) | 4.25 | 7.83 | 5.41 | 3.47 | 7.16 |
| PBT Margin (%) | 3.14 | 5.45 | 2.96 | 1.61 | 4.91 |
| Net Profit Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| NP After MI And SOA Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| Return on Networth / Equity (%) | 6.25 | 9.77 | 7.56 | 4.04 | 16.30 |
| Return on Capital Employeed (%) | 9.64 | 15.77 | 12.73 | 7.88 | 15.02 |
| Return On Assets (%) | 3.04 | 5.05 | 3.15 | 1.36 | 5.59 |
| Long Term Debt / Equity (X) | 0.02 | 0.12 | 0.31 | 0.62 | 0.46 |
| Total Debt / Equity (X) | 0.37 | 0.34 | 0.76 | 1.04 | 0.99 |
| Asset Turnover Ratio (%) | 1.47 | 1.43 | 1.49 | 1.46 | 1.44 |
| Current Ratio (X) | 1.35 | 1.54 | 1.26 | 1.17 | 1.07 |
| Quick Ratio (X) | 0.63 | 0.77 | 0.73 | 0.67 | 0.62 |
| Inventory Turnover Ratio (X) | 5.64 | 5.05 | 6.15 | 6.25 | 5.49 |
| Interest Coverage Ratio (X) | 3.93 | 4.44 | 3.25 | 3.04 | 4.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.52 | 1.86 | 1.52 | 3.07 |
| Enterprise Value (Cr.) | 446.96 | 559.15 | 501.39 | 729.76 | 852.31 |
| EV / Net Operating Revenue (X) | 0.67 | 0.94 | 0.83 | 1.27 | 1.83 |
| EV / EBITDA (X) | 9.85 | 8.98 | 10.43 | 22.50 | 18.71 |
| MarketCap / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| Price / BV (X) | 1.46 | 2.15 | 2.14 | 4.19 | 5.33 |
| Price / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| EarningsYield | 0.04 | 0.04 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Aarti Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.20. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 17.20, marking a decrease of 9.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 25.16 (Mar 24) to 17.19, marking a decrease of 7.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 37.67. This value is within the healthy range. It has decreased from 44.13 (Mar 24) to 37.67, marking a decrease of 6.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 778.53. It has increased from 696.75 (Mar 24) to 778.53, marking an increase of 81.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 53.62. This value is within the healthy range. It has decreased from 73.54 (Mar 24) to 53.62, marking a decrease of 19.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.13. This value is within the healthy range. It has decreased from 54.60 (Mar 24) to 33.13, marking a decrease of 21.47.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.45. This value is within the healthy range. It has decreased from 38.02 (Mar 24) to 24.45, marking a decrease of 13.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For PBDIT Margin (%), as of Mar 25, the value is 6.88. This value is below the healthy minimum of 10. It has decreased from 10.55 (Mar 24) to 6.88, marking a decrease of 3.67.
- For PBIT Margin (%), as of Mar 25, the value is 4.25. This value is below the healthy minimum of 10. It has decreased from 7.83 (Mar 24) to 4.25, marking a decrease of 3.58.
- For PBT Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 10. It has decreased from 5.45 (Mar 24) to 3.14, marking a decrease of 2.31.
- For Net Profit Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 5. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 8. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.25. This value is below the healthy minimum of 15. It has decreased from 9.77 (Mar 24) to 6.25, marking a decrease of 3.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 15.77 (Mar 24) to 9.64, marking a decrease of 6.13.
- For Return On Assets (%), as of Mar 25, the value is 3.04. This value is below the healthy minimum of 5. It has decreased from 5.05 (Mar 24) to 3.04, marking a decrease of 2.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.02, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.37, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 1.43 (Mar 24) to 1.47, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.35, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 24) to 0.63, marking a decrease of 0.14.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.05 (Mar 24) to 5.64, marking an increase of 0.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 3.93, marking a decrease of 0.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.52 (Mar 24) to 1.90, marking a decrease of 0.62.
- For Enterprise Value (Cr.), as of Mar 25, the value is 446.96. It has decreased from 559.15 (Mar 24) to 446.96, marking a decrease of 112.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.67, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from 8.98 (Mar 24) to 9.85, marking an increase of 0.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For Price / BV (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 1.46, marking a decrease of 0.69.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aarti Surfactants Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.64% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.25% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.6 (Industry average Stock P/E: 65.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
Fundamental Analysis of Aarti Surfactants Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot Nos. 57, 58, 60 to 64, 62A, S-3/1, Sector-3, Sagore Village, Dhar District Madhya Pradesh 454775 | investors@aarti-surfactants.com http://www.aarti-surfactants.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mulesh Manilal Savla | Chairman & Ind.Director |
| Mr. Nikhil Parimal Desai | Managing Director |
| Mr. Santosh Madhaorao Kakade | Executive Director |
| Mr. Chandrakant Vallabhaji Gogri | Non Executive Director |
| Mr. Dattatray Sidram Galpalli | Non Executive Director |
| Mrs. Misha Bharat Gala | Independent Director |
Aarti Surfactants Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹684.25 |
| Previous Day | ₹691.25 |
FAQ
What is the intrinsic value of Aarti Surfactants Ltd?
Aarti Surfactants Ltd's intrinsic value (as of 07 December 2025) is 260.86 which is 35.11% lower the current market price of 402.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 340 Cr. market cap, FY2025-2026 high/low of 684/388, reserves of ₹228 Cr, and liabilities of 490 Cr.
What is the Market Cap of Aarti Surfactants Ltd?
The Market Cap of Aarti Surfactants Ltd is 340 Cr..
What is the current Stock Price of Aarti Surfactants Ltd as on 07 December 2025?
The current stock price of Aarti Surfactants Ltd as on 07 December 2025 is 402.
What is the High / Low of Aarti Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aarti Surfactants Ltd stocks is 684/388.
What is the Stock P/E of Aarti Surfactants Ltd?
The Stock P/E of Aarti Surfactants Ltd is 22.6.
What is the Book Value of Aarti Surfactants Ltd?
The Book Value of Aarti Surfactants Ltd is 280.
What is the Dividend Yield of Aarti Surfactants Ltd?
The Dividend Yield of Aarti Surfactants Ltd is 0.25 %.
What is the ROCE of Aarti Surfactants Ltd?
The ROCE of Aarti Surfactants Ltd is 8.50 %.
What is the ROE of Aarti Surfactants Ltd?
The ROE of Aarti Surfactants Ltd is 5.14 %.
What is the Face Value of Aarti Surfactants Ltd?
The Face Value of Aarti Surfactants Ltd is 10.0.